85 Five years of sequential LAM TO LAM+ADV therapy suppresses HBV replication in most HBeAg-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma

✍ Scribed by P. Lampertico; M. Viganò; E. Manenti; M. Iavarone; G. Lunghi; M. Colombo

• Book ID: 117374366
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 105 KB
• Volume: 44
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(06)80086-3